TREATMENT OUTCOMES OF FACIAL CONGENITAL MELANOCYTIC NEVI USING NATURAL SKIN EXPANSION AT GENERAL LONG AN HOSPITAL

Quang Thành Lê1, , Duy Trinh Phan1, Trần Tuấn Anh Nguyễn1, Đặng Lan Hương Bùi2, Tùng Hiệp Bùi3, Đặng Phương Chi Bùi3, Đặng Minh Trí Bùi3
1 Bệnh viện Đa khoa Long An
2 Bệnh viện Từ Dũ
3 Trường Đại học Y khoa Phạm Ngọc Thạch

Main Article Content

Abstract

Objective: To evaluate outcomes of natural skin expansion using staged serial excision for facial congenital melanocytic nevi (CMN) and explore the association between treatment complications and scar quality at 6 months.


Subjects and Methods: A prospective longitudinal descriptive study with analysis included 27 patients with facial CMN enrolled in 2022 and treated and followed through December 2025 at General Long An Hospital. Lesions underwent staged serial excision with direct closure without tissue expanders. Six-month outcomes included excision status, complications, facial function, the POSAS Observer Scale, and SCAR-Q in patients aged 8 years or older. POSAS scores were compared by complication status using a two-sided Mann–Whitney U test.


Results: Mean age was 9.7 ± 5.2 years, mean lesion diameter 8.4 ± 3.1 cm, and mean number of operations 2.9 ± 0.9. Complete clinical excision was achieved in 85.2%; 25.9% had at least one complication and 92.6% had no functional impairment at 6 months. Mean total POSAS was 12.3 ± 4.1. Among 16 SCAR-Q respondents, Appearance, Symptoms, and Psychosocial Impact scores were 78.4 ± 13.5, 87.8 ± 8.6, and 81.8 ± 11.9, respectively. Median POSAS was higher in patients with complications: 16.5 (IQR 14.5–17.8) versus 10.3 (IQR 8.8–13.6), p = 0.016.


Conclusion: Staged serial excision using natural skin expansion produced favorable outcomes in selected facial CMN, with high functional preservation and relatively favorable scar results. Complications were associated with higher POSAS scores in an exploratory analysis.

Article Details

References

1. Xie Y, Chen Q, Li T, et al. Surgical management of facial congenital melanocytic nevi: Experiences and outcomes at an academic center. Journal of Cosmetic Dermatology. 2022;21(11):5811–5818.
2. Bennaceur S, Berdah S, Amoric JC, Levan P, Chrétien-Marquet B. Natural skin expansion. Applications to the surgery of nevus of the head and neck in children. Annales de Chirurgie Plastique et Esthétique. 1996;41(4):338–345.
3. Nguyen Hong S, Dinh Huu N, Nguyen Duy N, et al. Serial Excision for the Treatment of Giant Congenital Melanocytic Nevus: The Vietnamese Way. Open Access Macedonian Journal of Medical Sciences. 2019;7(2):231–233.
4. Van de Kar AL, Corion LUM, Smeulders MJC, Draaijers LJ, van der Horst CMAM, van Zuijlen PPM. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plastic and Reconstructive Surgery. 2005;116(2):514–522.
5. Ziolkowski NI, Pusic AL, Fish JS, et al. Psychometric Findings for the SCAR-Q Patient-Reported Outcome Measure Based on 731 Children and Adults with Surgical, Traumatic, and Burn Scars from Four Countries. Plastic and Reconstructive Surgery. 2020;146(3):331e–338e.
6. Hassanein AH, Rogers GF, Greene AK. Management of challenging congenital melanocytic nevi: outcomes study of serial excision. Journal of Pediatric Surgery. 2015;50(4):613–616.
7. Chowchuen B. Long-term outcomes of surgical management in the patients with facial congenital melanocytic nevi. Journal of the Medical Association of Thailand. 2011;94(Suppl 6):S70–S78.
8. Howard T, Sindi A, Quong W, et al. Surgical management of pediatric facial Congenital Melanocytic Naevi and use of the novel Patient-Reported Outcome Measure: SCAR-Q to assess outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;113:315–322.